<DOC>
	<DOCNO>NCT01971957</DOCNO>
	<brief_summary>Sjogren-Larsson syndrome ( SLS ) rare genetic disease patient typically exhibit ichthyosis ( dry , scaly skin ) , intellectual disability , spasticity , seizures distinctive maculopathy . The purpose study define clinical spectrum natural history Sjogren-Larsson syndrome , identify biomarkers correlate disease phenotype establish registry future investigation biochemical pathogenesis therapy .</brief_summary>
	<brief_title>Sjogren-Larsson Syndrome : Natural History , Clinical Variation Evaluation Biochemical Markers</brief_title>
	<detailed_description>The study consist clinical component scientific component consist laboratory investigation potentially useful biochemical ( lipid protein ) marker . Up 50 SLS patient age , gender ethnic origin enrol . A detailed clinical evaluation perform determine presence extent disease involve skin , nervous system eye . Clinical test include brain magnetic resonance imaging ( MRI ) spectroscopy ( MRS ) , electroencephalography ( EEG ) , neurocognitive test , ophthalmologic examination retinal photograph optical coherence tomography ( OCT ) , photographs skin test cutaneous transepidermal water loss . Laboratory investigation include lipid analysis ( e.g . fatty alcohol , farnesol , fatty acid , ether glycerolipids , etc . ) blood , skin urine ; proteomic analysis skin ( stratum corneum ) ; measurement leukocyte fatty alcohol farnesol oxidation . A skin biopsy ( optional ) obtain electron microscopy , measurement lanthanum perfusion ( transepidermal water loss ) , and/or establish keratinocyte culture . Correlations clinical abnormality laboratory measurement test identify useful biomarkers future diagnostic therapeutic study . To characterize progression phenotypic feature time , patient &lt; 6 year age follow yearly patient â‰¥6 year age follow every 3 year . In addition , SLS patient registry establish resource future investigation SLS .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Sjogren 's Syndrome</mesh_term>
	<mesh_term>Sjogren-Larsson Syndrome</mesh_term>
	<criteria>The eligibility criterion subject genetically biochemically confirm diagnosis SjogrenLarsson syndrome . The primary exclusion criterion patient ' failure consent inability travel STAIR site .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>ichthyosis</keyword>
	<keyword>spasticity</keyword>
	<keyword>spastic diplegia</keyword>
	<keyword>intellectual disability</keyword>
</DOC>